IL6 and cancer: The identification of miR-21 as a direct transcriptional target of STAT3 firmly places it within the inflammation-cancer axis, suggesting that the pro-tumorigenic effects of chronic inflammation (e.g., mediated by IL-6) in the stomach may be, at least in part, channeled through miR-21 upregulation.